Advisory Board - TAO-CTM Meeting

Dr. Matti Aapro, Switzerland

Medical Oncologist, board member of the Genolier Cancer Center at the Clinique de Genolier. Member of several learned societies, including the SIOG, ECCO (President) AFSOS (Honorary Chairman), ESMO (faculty member), MASCC (former chairman), ESO and SPCC. Founding editor of the Journal of Geriatric Oncology.Honorary Editor of Critical Reviews in Oncology/Hematology.Associate Editor of the geriatrics section of the journal The Oncologist. Specialist in innovative treatments, breast cancer, geriatric oncology, and supportive care.

Dr. Joël Epstein, United States

Stomatologist, Professor and Medical Director of the Cancer Dentistry Program at the Cedars-Sinai Samuel Oschin Comprehensive Cancer Institute in Los Angeles. Director of the Dental Oncology Department and consultant in the Otolaryngology, Head and Neck Surgery Department of the City of Hope National Medical Center in Duarte, California. Professor at the Department of Dentistry and Diagnostics, Director of the Interdisciplinary Program in Oral Cancer Biology, Prevention, and Treatment at the Chicago Cancer Center, College of Medicine. Adjunct Professor at the Department of Otolaryngology, Head of the Surgery Division at the University of Illinois, Chicago, Illinois.

Pr. Richard Gralla, United States

Medical Oncologist, Professor of Medicine at the Albert Einstein College of Medicine in New York and Director of Oncology Research at Jacobi Medical Center. Former Chief of the Thoracic Oncology Service at Memorial Sloan-Kettering Cancer Center in New York, Director of the Ochsner Cancer Institute in New Orleans, and Vice President for Cancer Services at Northwell Health in New York.

Dr. Jeffrey Crawford, United States

Medical Oncologist, co-leader of the Solid Tumor Therapeutics Program at the Duke Cancer Institute in Durham, North Carolina. Areas of interest: lung cancer, therapeutics, hematopoietic growth factors, and cachexia.

Dr. Mario Dicato, Luxembourg

Head of Hematology-Oncology Service at Luxembourg Medical Center in Luxembourg, and Head of the Research Laboratory of the Luxembourg Foundation for Research on Cancer and Blood Disorders.
Trained at Lausanne University (Switzerland). Postgraduate training in internal medicine at the Universities of Geneva, (Switzerland), Pittsburgh and Yale (USA). Fellowship (subspecialty training) in hematology at the Massachusetts General Hospital, Boston and Clinical and Research Fellow in Medicine at Harvard University, Boston, (USA).
Member of various scientific societies including the ASCO and the ESMO. He has published more than 250 papers and numerous book chapters, and is an editorial board member of several scientific journals.

Dr. Pere Gascon, Spain

Internist, Head of the Medical Oncology Department and Scientific Coordinator of the clinical institute of hematology/oncology diseases (ICMHO) at the Barcelona clinical hospital. Certified by the American Board of Internal Medicine, the Internal Medicine, Hematology and Oncology Division. Member of Alpha Omega Alpha Honor, an honor society in the field of medicine in the United States.

Dr. Fausto Roila, Italy

Medical Oncologist, Director of the Medical Oncology Division of the Santa Maria della Misericordia of Perugia Hospital. Member of several oncological societies, including the AIOM, ESMO, ASCO and MASCC. Since 1985 he has been involved in antiemetic prophylaxis of chemotherapy-induced nausea and vomiting publishing over 40 articles on the best international medical journals..

AFSOS: Association Francophone des Soins Oncologiques de Support [Francophone association of supportive oncological care]. AIOM: Italian Association for Medical Oncology. ASCO : American Society of Clinical Oncology ECCO: European CanCer Organisation. ESMO: European Society for Medical Oncology. ESO: European School of Oncology. MASCC: Multinational Association of Supportive Care in Cancer. SIOG: International Society for Geriatric Oncology. SPCC : Sharing Progress in Cancer Care.